{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.085B vs. cons $1.093B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic revenue growth",
      "prediction": "MISS",
      "answer": "pred ~6.8% vs. cons 7.02%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating diluted EPS",
      "prediction": "MISS",
      "answer": "pred ~$0.334 vs. cons $0.339",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Organic growth (FY2026)",
      "prediction": "BETTER",
      "answer": "guide 7%\u20138% vs. cons 7.16%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "M&A contribution (FY2026)",
      "prediction": "UNKNOWN",
      "answer": "guide 2%\u20133% vs. cons UNVERIFIED",
      "confidence": "LOW"
    },
    {
      "kpi": "Incremental margin / peak-season commentary (FY2026)",
      "prediction": "UNKNOWN",
      "answer": "maintain framework; Q2 conversion softer",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -3.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 implied H2 burden risks revisions",
  "day5_confidence": "LOW"
}